Cargando…
Metabolic Signature-Based Subtypes May Pave Novel Ways for Low-Grade Glioma Prognosis and Therapy
Metabolic signatures are frequently observed in cancer and are starting to be recognized as important regulators for tumor progression and therapy. Because metabolism genes are involved in tumor initiation and progression, little is known about the metabolic genomic profiles in low-grade glioma (LGG...
Autores principales: | Li, Ganglei, Wu, Zhanxiong, Gu, Jun, Zhu, Yu, Zhang, Tiesong, Wang, Feng, Huang, Kaiyuan, Gu, Chenjie, Xu, Kangli, Zhan, Renya, Shen, Jian |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8650219/ https://www.ncbi.nlm.nih.gov/pubmed/34888308 http://dx.doi.org/10.3389/fcell.2021.755776 |
Ejemplares similares
-
RNA modification patterns based on major RNA modifications define tumor microenvironment characteristics in glioblastoma
por: Li, Ganglei, et al.
Publicado: (2022) -
Inflammation and Oxidative Stress: Potential Targets for Improving Prognosis After Subarachnoid Hemorrhage
por: Wu, Fan, et al.
Publicado: (2021) -
Foxo1‐induced miR‐92b down‐regulation promotes blood‐brain barrier damage after ischaemic stroke by targeting NOX4
por: Shen, Jian, et al.
Publicado: (2021) -
Expression and Functional Roles of Eukaryotic Initiation Factor 4A Family Proteins in Human Cancers
por: Xue, Chen, et al.
Publicado: (2021) -
Immune Infiltration-Related Signature Predicts Risk Stratification and Immunotherapy Efficacy in Grade II and III Gliomas
por: Luo, Cong, et al.
Publicado: (2021)